Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Given Extensions to Meet Nasdaq Listing Requirements

Premium

Rosetta Genomics this week announced that it has received notice from the Nasdaq that it has been given an extension to regain compliance with the exchange's $2.5 million minimum stockholders' equity requirement for continued listing.

Under the terms of the extension, Rosetta must regain compliance by the quarter ended June 30. The company must meet certain milestones toward regaining compliance by Feb. 28 and April 29, as well.

Rosetta said that it has also been given an extension for meeting the Nasdaq's $1 minimum bid requirement, and now has until Aug. 8 to do so.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more